Compare RGEN & JBTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | JBTM |
|---|---|---|
| Founded | 1981 | 1994 |
| Country | United States | United States |
| Employees | 2000 | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 6.9B |
| IPO Year | 1995 | 2008 |
| Metric | RGEN | JBTM |
|---|---|---|
| Price | $186.79 | $113.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $167.67 | ★ $180.00 |
| AVG Volume (30 Days) | ★ 840.6K | 451.3K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.34% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | 0.24 | ★ 1.40 |
| Revenue | $141,236,000.00 | ★ $3,798,200,000.00 |
| Revenue This Year | $14.30 | $8.10 |
| Revenue Next Year | $14.52 | $4.68 |
| P/E Ratio | $778.13 | ★ $80.96 |
| Revenue Growth | 35.10 | ★ 121.34 |
| 52 Week Low | $100.99 | $109.63 |
| 52 Week High | $188.73 | $170.19 |
| Indicator | RGEN | JBTM |
|---|---|---|
| Relative Strength Index (RSI) | 67.84 | 42.85 |
| Support Level | $158.15 | N/A |
| Resistance Level | $188.73 | $120.86 |
| Average True Range (ATR) | 5.75 | 2.75 |
| MACD | 1.05 | 0.44 |
| Stochastic Oscillator | 96.88 | 38.55 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.